ATE122678T1 - Ceftazidim-dihydrochlorid-ameisensäuresolvate. - Google Patents

Ceftazidim-dihydrochlorid-ameisensäuresolvate.

Info

Publication number
ATE122678T1
ATE122678T1 AT89301004T AT89301004T ATE122678T1 AT E122678 T1 ATE122678 T1 AT E122678T1 AT 89301004 T AT89301004 T AT 89301004T AT 89301004 T AT89301004 T AT 89301004T AT E122678 T1 ATE122678 T1 AT E122678T1
Authority
AT
Austria
Prior art keywords
formic acid
ceftazidim
dihydrochloride
acid solvate
solvate
Prior art date
Application number
AT89301004T
Other languages
German (de)
English (en)
Inventor
Colin Robinson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE122678T1 publication Critical patent/ATE122678T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT89301004T 1988-02-05 1989-02-02 Ceftazidim-dihydrochlorid-ameisensäuresolvate. ATE122678T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888802622A GB8802622D0 (en) 1988-02-05 1988-02-05 Chemical compound

Publications (1)

Publication Number Publication Date
ATE122678T1 true ATE122678T1 (de) 1995-06-15

Family

ID=10631146

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89301004T ATE122678T1 (de) 1988-02-05 1989-02-02 Ceftazidim-dihydrochlorid-ameisensäuresolvate.

Country Status (9)

Country Link
US (1) US4943632A (ja)
EP (1) EP0327358B1 (ja)
JP (1) JP2780800B2 (ja)
KR (1) KR0123015B1 (ja)
AT (1) ATE122678T1 (ja)
DE (1) DE68922629T2 (ja)
ES (1) ES2072293T3 (ja)
GB (1) GB8802622D0 (ja)
TW (1) TW266212B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2514092C (en) * 2003-01-21 2013-03-19 S.S.C.I., Inc. Novel cocrystallization of hydrochloric acid salt of an active agent
EP1740930A4 (en) 2004-03-12 2010-09-15 Aptuit Kansas City Llc SEARCH FOR FORMATS BY ULTRASOUND CRYSTALLIZATION AND COKRISTALLIZATION USING ULTRASOUND
HUP0700353A2 (en) 2007-05-18 2008-12-29 Richter Gedeon Nyrt Metabolites of (thio)carbamoyl-cyclohexane derivatives
US20110059980A1 (en) * 2008-02-21 2011-03-10 Yasuaki Oobayashi Solid preparation for oral administration
RS53866B1 (en) 2008-07-16 2015-08-31 Richter Gedeon Nyrt. PHARMACEUTICAL FORMULATIONS CONTAINING DOPAMINE RECEPTOR LIGANDS
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder
KR20210015065A (ko) 2019-07-31 2021-02-10 김윤성 운전자의 개성을 표현하고 운전자, 보행자, 자동차를 보호하기 위한 차량용 보호 케이스

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR229883A1 (es) * 1978-05-26 1983-12-30 Glaxo Group Ltd Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato
US4329453A (en) * 1979-10-02 1982-05-11 Glaxo Group Limited Cephalosporin antibiotic
NZ195116A (en) * 1979-10-02 1982-09-07 Glaxo Group Ltd The crystalline bishydrochloride of a certain cephalosporin medicinal preparations
GB2132616B (en) * 1982-12-27 1986-08-06 Lilly Co Eli Improvements in or relating to novel cephalosporin intermediates
US4537959A (en) * 1984-03-26 1985-08-27 Eli Lilly And Company Crystalline cephalosporin antibiotic salt
EP0166580A3 (en) * 1984-06-25 1987-03-18 Eli Lilly And Company Improvements in or relating to ceftazidime
US4616080A (en) * 1984-07-02 1986-10-07 Eli Lilly And Company Simplified process of forming crystalline ceftazidime pentahydrate

Also Published As

Publication number Publication date
ES2072293T3 (es) 1995-07-16
EP0327358A3 (en) 1991-04-03
TW266212B (ja) 1995-12-21
EP0327358B1 (en) 1995-05-17
KR890013031A (ko) 1989-09-21
DE68922629T2 (de) 1995-10-19
KR0123015B1 (ko) 1997-11-13
EP0327358A2 (en) 1989-08-09
US4943632A (en) 1990-07-24
DE68922629D1 (de) 1995-06-22
JPH01308284A (ja) 1989-12-12
JP2780800B2 (ja) 1998-07-30
GB8802622D0 (en) 1988-03-02

Similar Documents

Publication Publication Date Title
UA7208A1 (uk) Спосіб одержання пентагідрату (6r,7r)-7-[(z)-2-(2-амінотіазол-4-іл)-2-(2-карбоксіпроп-2-оксііміно)-ацетамідо]-3-(1-пирідинійметил)-цеф-3-ем-4-карбоксилату
IL59793A (en) Derivatives of(6r,7r)-7-((z)-2-(2-aminothiazol-4-yl)-2-(carboxy-(lower alkyl or cycloalkyl)oxyimino)acetamido)-3-(1-pyridinium-methyl)ceph-3-em-4-carboxylate,process for their preparation and pharmaceutical compositions comprising them
ES467828A1 (es) Un procedimiento para preparar nuevos compuestos de cefem y cefam
ATE122678T1 (de) Ceftazidim-dihydrochlorid-ameisensäuresolvate.
IL58717A (en) Derivatives of(6r,7r)-7-((z)-2-(2-aminothiazol-4-yl)-2-(carboxy-(lower alkyl or cycloalkyl)oxyimino)acetamido)-3-(2-alkyl-pyrazolium-1-ylmethyl)ceph-3-em-4-carboxylate,process for their preparation and pharmaceutical compositions comprising them
AU571506B2 (en) Cristalline ceftazidime
SE8104771L (sv) Cefalosporinderivat
ATE3550T1 (de) Kristalline salze eines cephalosporins, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ES8702918A1 (es) Un procedimiento para la preparacion de dihidrobromuro de acido (6r,7r)-7-((z)-2-(2-tritilaminotiazol-4-il)-2-(2-t-butiloxicarbonil-prop-2-oximino)acetamido)-3-(1piridiniometil)-3-cefem-4-carboxilico cristalino.
DE69032733D1 (de) Lyophilisiertes Dihydrochloridsalz von 7-[alpha-(2-Aminothiazol-4-yl)-alpha-(Z)-methoxyiminoacetamid]-3-[(1-methyl-1-pyrrolidinium)-methyl]-3-cephem-4-carboxylsäure
ATE31535T1 (de) Cephalosporinverbindungen.
ES8501768A1 (es) Procedimiento para preparar (6r, 7r)-7-( (z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oximino)-acetamido)-3-(1-piridiniometil)-cef-3-em-carboxilato x 1, 5 moles de agua, cristalizado
DK536986D0 (da) Cephalosporinderivater, deres fremstilling og anvendelse
ATE82977T1 (de) Kristalline cephalosporinderivate.
ES513929A0 (es) Procedimiento para la obtencion de cefalosporina 7-aca.
NO884486L (no) Fremgangsmaate for fremstilling av cefalosporinderivater med forbedrede farmakokinetika.
JPS6466191A (en) Novel cephalosporin derivative and antibacterial
JPS52108994A (en) Antibiotics of cephalosporin series

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time